1 active not recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
Follow Malignant Mesothelioma, Advanced: new trials by email Literature Review of Malignant Mesothelioma, Advanced trials Research Report on Malignant Mesothelioma, Advanced
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers CK-301 (cosibelimab) - Lung Neoplasms, Carcinoma, Non-Small-Cell Lung | Phase 1 | Active not recruiting | Checkpoint Therapeutics, Inc. | 272 | 2017-09-20 | 2025-02-03 |
Carcinoma, Merkel Cell (1) · Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Carcinoma, Small Cell (1) · Carcinoma, Transitional Cell (1) · Endometrial Neoplasms (1) · Head and Neck Neoplasms (1) · Lung Neoplasms (1) · Lymphoma, Non-Hodgkin (1) · Melanoma (1) · Mesothelioma, Malignant (1) · Neoplasms (1) · Skin Neoplasms (1)
Adenocarcinoma (1) · Adenoma (1) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Carcinoma, Neuroendocrine (1) · DNA Virus Infections (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1)
Checkpoint Therapeutics, Inc. (1)
Australia (1) · France (1) · New Zealand (1) · Poland (1) · Russia (1) · South Africa (1) · Spain (1) · Thailand (1) · Ukraine (1)